Monoclonal Antibody
- All
- News
- Videos
-
Nipah Virus Endemic In Kerala And West Bengal, Warns Doctor
Nipah virus outbreak in India as Kerala and West Bengal declared endemic. Dr Arora highlights high mortality, limited monoclonal antibodies, and urgent need for vigilance.
-
Nipah Virus Crisis: Doctor Urges Global Preparedness Against Possible Spread
Nipah virus poses severe health risks, causing brain infection and pneumonia with high death rates. Dr Rajeev Jayadevan stresses early diagnosis, isolation and contact tracing.
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
Lab Antibody Cuts Severe Respiratory Infection In Infants By Over 80%: Report
A monoclonal antibody -- a protein created in a lab which mimics the work of a natural antibody -- could be highly effective in preventing severe RSV, a respiratory infection and major cause of serious illness in infants, according to a research.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
India To Get 20 More Doses Of Antibody From Australia To Treat Nipah
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR) said on Friday.
-
India To Get These Antibodies From Australia For Nipah Treatment
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, ICMR DG Rajeev Bahl said on Friday.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
Omicron May Not Evade All Monoclonal Antibodies, Study Suggests
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
-
Nipah Virus Endemic In Kerala And West Bengal, Warns Doctor
Nipah virus outbreak in India as Kerala and West Bengal declared endemic. Dr Arora highlights high mortality, limited monoclonal antibodies, and urgent need for vigilance.
-
Nipah Virus Crisis: Doctor Urges Global Preparedness Against Possible Spread
Nipah virus poses severe health risks, causing brain infection and pneumonia with high death rates. Dr Rajeev Jayadevan stresses early diagnosis, isolation and contact tracing.
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
Lab Antibody Cuts Severe Respiratory Infection In Infants By Over 80%: Report
A monoclonal antibody -- a protein created in a lab which mimics the work of a natural antibody -- could be highly effective in preventing severe RSV, a respiratory infection and major cause of serious illness in infants, according to a research.
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
India To Get 20 More Doses Of Antibody From Australia To Treat Nipah
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR) said on Friday.
-
India To Get These Antibodies From Australia For Nipah Treatment
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, ICMR DG Rajeev Bahl said on Friday.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
Omicron May Not Evade All Monoclonal Antibodies, Study Suggests
The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.
